Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | FAAH | O00519 | 5/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 5/20 | 0.34 |
| ▸ | CES2 | O00748 | 2/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17092516 | 1.00 | CA2 (0.37) | CA2FAAHCA1CA7CA13 | |
| SCHEMBL5469606 | 0.97 | CA2 (0.37) | CA2FAAHCA1CA7CA13 | |
| SCHEMBL21414876 | 0.90 | CA1 (0.37) | CA2CA1CA7CA13EPHX1 | |
| SCHEMBL4076093 | 0.87 | FAAH (0.56) | CA2FAAHCES1CES2EPHX1 | |
| SCHEMBL20603828 | 0.87 | CA2 (0.31) | CA2FAAH | |
| SCHEMBL23520532 | 0.87 | FAAH (0.56) | CA2FAAHCES1CES2EPHX1 | |
| SCHEMBL1321107 | 0.87 | CA2 (0.38) | CA2CA1CA7CA13ALDH1A1 | |
| SCHEMBL1319976 | 0.87 | CA2 (0.38) | CA2CA1CA7CA13ALDH1A1 | |
| SCHEMBL1318735 | 0.87 | CA2 (0.38) | CA2CA1CA7CA13ALDH1A1 | |
| SCHEMBL1319037 | 0.87 | CA2 (0.38) | CA2CA1CA7CA13ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020114150-A1 | SYNTHESIS METHOD FOR SYNTHESIZING CARBAMATE USING DIMETHYL SULFOXIDE YLIDE, AMINE AND CARBON DIOXIDE | 华南理工大学 | 2020-06-11 | — | — | WO | claimed |
| US-9064633-B2 | Method for synthesizing quaternary ammonium systems | HONEYWELL INTERNATIONAL INC. (US) | 2015-06-23 | — | — | US | claimed |
| CN-104356259-A | Olefin polymerization catalyst and combined catalyst containing same | PETROCHINA CO LTD | 2015-02-18 | — | — | CN | claimed |
| US-20130264510-A1 | METHOD FOR SYNTHESIZING QUATERNARY AMMONIUM SYSTEMS | HONEYWELL INT INC (US) | 2013-10-10 | — | — | US | claimed |
| US-8426593-B2 | Method for synthesizing quaternary ammonium systems | HONEYWELL INTERNATIONAL INC. (US) | 2013-04-23 | — | — | US | claimed |
| US-20070049750-A1 | Method for synthesizing spiro quartenary ammonium systems | HONEYWELL INTERNATIONAL INC. (US) | 2007-03-01 | — | — | US | claimed |
| CN-104356259-A | Olefin polymerization catalyst and combined catalyst containing same | PETROCHINA CO LTD | 2015-02-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070049750-A1 | Method for synthesizing spiro quartenary ammonium systems | REN, AGT, PKD1 | CA2 432/4885FAAH 4423/4885CA1 1237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.